Isolated blast crisis in CNS in a patient with chronic myelogenous leukemia maintaining major cytogenetic response after imatinib

J Clin Oncol. 2006 Aug 20;24(24):4028-9. doi: 10.1200/JCO.2006.05.5608.

Authors

Hyun Jung Kim¹, Chul Won Jung, Kihyun Kim, Jin Seok Ahn, Won Seog Kim, Kwan Park, Young Hye Ko, Won Ki Kang, Keunchil Park

Affiliation

¹ Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

PMID: 16921058
DOI: 10.1200/JCO.2006.05.5608

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Benzamides
Blast Crisis / etiology*
Blast Crisis / pathology
Cerebellum / pathology*
Drug Administration Schedule
Fatal Outcome
Humans
Imatinib Mesylate
In Situ Hybridization, Fluorescence
Injections, Spinal
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications*
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
Male
Piperazines / therapeutic use*
Pyrimidines / therapeutic use*

Substances

Benzamides
Piperazines
Pyrimidines
Imatinib Mesylate